Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - ketamine hydrochloride, quantity: 11.53 mg/ml (equivalent: ketamine, qty 10 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride; sodium hydroxide - ketamine interpharma? is recommended:,1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketamine interpharma ? is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents; 3. to supplement low-potency agents, such as nitrous oxide.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - ketamine hydrochloride, quantity: 57.67 mg/ml (equivalent: ketamine, qty 50 mg/ml) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - ketamine interpharma? is recommended:,1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketamine interpharma ? is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents; 3. to supplement low-potency agents, such as nitrous oxide.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - ketamine hydrochloride, quantity: 57.67 mg/ml (equivalent: ketamine, qty 50 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide - ketamine interpharma? is recommended:,1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketamine interpharma ? is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents; 3. to supplement low-potency agents, such as nitrous oxide.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - ketamine hydrochloride, quantity: 11.53 mg/ml (equivalent: ketamine, qty 10 mg/ml) - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide; hydrochloric acid - ketamine interpharma? is recommended:,1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketamine interpharma ? is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents; 3. to supplement low-potency agents, such as nitrous oxide.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - ketamine hydrochloride, quantity: 57.67 mg/ml (equivalent: ketamine, qty 50 mg/ml) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - ketamine interpharma? is recommended:,1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketamine interpharma ? is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents; 3. to supplement low-potency agents, such as nitrous oxide.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - ketamine hydrochloride, quantity: 11.53 mg/ml (equivalent: ketamine, qty 10 mg/ml) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium hydroxide - ketamine interpharma? is recommended:,1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketamine interpharma ? is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents; 3. to supplement low-potency agents, such as nitrous oxide.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - ephedrine hydrochloride, quantity: 30 mg - injection, solution - excipient ingredients: sodium chloride; sodium citrate; citric acid; water for injections - ephedrine interpharma injection is indicated in the treatment of hypotension secondary to spinal anaesthesia.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - carbetocin, quantity: 100 microgram - injection, solution - excipient ingredients: glacial acetic acid; water for injections; sodium chloride - carbetocin interpharma is indicated for the prevention of uterine atony and excessive bleeding following delivery of the infant by caesarean section or vaginal delivery.,carbetocin interpharma must be administered after delivery of the infant.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - pemetrexed disodium hemipentahydrate, quantity: 604.1 mg (equivalent: pemetrexed, qty 500 mg) - injection, concentrated - excipient ingredients: trometamol; hydrochloric acid; sodium hydroxide; water for injections; monothioglycerol; citric acid - malignant pleural mesothelioma,pemetrexed ever pharma, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,non-small cell lung cancer,pemetrexed ever pharma in combination with cisplatin is indicated for initial treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.,pemetrexed ever pharma as monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - pemetrexed disodium hemipentahydrate, quantity: 1208.21 mg (equivalent: pemetrexed, qty 1000 mg) - injection, concentrated - excipient ingredients: trometamol; hydrochloric acid; sodium hydroxide; water for injections; monothioglycerol; citric acid - malignant pleural mesothelioma,pemetrexed ever pharma, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,non-small cell lung cancer,pemetrexed ever pharma in combination with cisplatin is indicated for initial treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.,pemetrexed ever pharma as monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy.